Table 3 |
||||||
| Minimum inhibitory concentrations (MICs, mg/L) of cefixime and ceftriaxone for Neisseria gonorrhoeae (nā=ā108) isolated in Hanoi, Vietnam in 2011 | ||||||
| NG-MAST ST (No. of isolates) | Anti-microbial | No. of isolates with MIC (mg/L): | ||||
| ā¤0.016 | 0.032 | 0.064 | 0.125 | 0.25 | ||
| 4787 (11) | IX | 3 | 4 | 3 | 1 | |
| TX | 3 | 5 | 3 | |||
| 7720 (5)a | IX | 1 | 4 | |||
| TX | 5 | |||||
| 7741 (4)a | IX | 3 | 1 | |||
| TX | 4 | |||||
| 7155 (3)a | IX | 1 | 2 | |||
| TX | 2 | 1 | ||||
| 7724 (3)a | IX | 3 | ||||
| TX | 3 | |||||
| 3493 (2) | IX | 2 | ||||
| TX | 2 | |||||
| 7139 (2)a | IX | 2 | ||||
| TX | 2 | |||||
| 7140 (2)a | IX | 1 | 1 | |||
| TX | 2 | |||||
| 7159 (2)a | IX | 2 | ||||
| TX | 1 | 1 | ||||
| 7718 (2)a | IX | 2 | ||||
| TX | 2 | |||||
| 7722 (2)a | IX | 2 | ||||
| TX | 2 | |||||
| 7731 (2)a | IX | 2 | ||||
| TX | 2 | |||||
| 7734 (2)a | IX | 2 | ||||
| TX | 1 | 1 | ||||
| 7735 (2)a | IX | 2 | ||||
| TX | 1 | 1 | ||||
| 7736 (2)a | IX | 1 | 1 | |||
| TX | 2 | |||||
| 7739 (2)a | IX | 2 | ||||
| TX | 2 | |||||
| 7748 (2)a | IX | 1 | 1 | |||
| TX | 1 | 1 | ||||
| Unique STs (58)b | IX | 15 | 16 | 25 | 2 | |
| TX | 12 | 15 | 20 | 10 | 1 | |
NG-MAST, Neisseria gonorrhoeae multiantigen sequence typing; ST, sequence type;
MIC, minimum inhibitory concentration; IX, cefixime; TX, ceftriaxone.
aNew sequence types found in the present study.
bUnique STs represented by single isolates.
Olsen et al. BMC Infectious Diseases 2013 13:40 doi:10.1186/1471-2334-13-40